Products
Platform
Research
Market
Learn
Partner
Support
IPO

N

Nureca Share Price

326.85
+15.00 (4.81%)
NURECA • 19 Jan, 2026 | 02:59 PM

1Y Annualised Return

-24.68%

3Y Annualised Return

-8.11%

The current prices are delayed, login or Open Demat Account for live prices.

Nureca Stock Performance

1W Return16.94
1Y Return-20.08
Today's Low314
Prev. Close311.85
Mkt Cap (Cr.)311.88
1M Return15.19
3Y Return-2.35
52-Week High447.5
Open327.40
PE Ratio34.59
6M Return26.93
Today's High327.4
52-Week Low203.62
Face Value10

Nureca Company background

Founded in: 2016
Managing director: Saurabh Goyal
Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Companys differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, DirecttoConsumer (D2C) Excellence and InHouse Manufacturing Capabilities. The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives.In 2017, the Company commenced business operations and launched Dr. Trust brand through digital healthcare channel.In 2018, the Company widened product basket with launching of brands in electric massages and mother child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Companys key products secured a warehouse drug license.In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited and the Company and their respective shareholders and creditors and the Scheme became effective on 23 May 2020. Pursuant to Scheme of Demerger, certain portion of business activities of Nectar Biopharma Private Limited was transferred by Nectar Biopharma Private Limited from 01 April, 2019.Nureca Technologies Private Limited have received industrial policy approval to establish a health and wellness equipment manufacturing plant at Village Sundra, SAS Nagar, Punjab in FY 25.

Nureca Financial Highlights


For the full year FY2025–2026, revenue reached ₹122.1 crore and profit touched at ₹0.85 crore.

Nureca Share Price Today


As of 19 Jan 2026, Nureca share price is ₹326.8. The stock opened at ₹327.4 and had closed at ₹311.8 the previous day. During today’s trading session, Nureca share price moved between ₹314.00 and ₹327.40, with an average price for the day of ₹320.70. Over the last 52 weeks, the stock has recorded a low of ₹203.62 and a high of ₹447.50. In terms of performance, Nureca share price has increased by 26.9% over the past six months and has declined by 24.68% over the last year.
Read More
Nureca SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 3 years with a gain of 0 (+0.00%)
View details of Market Depth

Nureca Fundamental

Market Cap (in crs)

311.88

Face Value

10

Turnover (in lacs)

426.24

Key Metrics

Qtr Change %
26.96% Fall from 52W High
13
Dividend yield 1yr %
0

Nureca Key Financials

View more
Loading chart...
Nureca Quarterly Revenue
Nureca Yearly Revenue
Nureca Quarterly Net Profit/Loss
Nureca Yearly Net Profit/Loss

Nureca Result Highlights

  • Nureca Ltd reported a 4.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 49.7%.

  • Its expenses for the quarter were up by 4.8% QoQ and 19.1% YoY.

  • The net profit increased 2.8% QoQ and decreased 233.2% YoY.

  • The earnings per share (EPS) of Nureca Ltd stood at 3.91 during Q3 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Nureca Shareholding Pattern

Promoter
65%
Foreign Institutions
0.1%
Public
34.9%

Nureca Technical Analysis

Moving Averages Analysis
326.85
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Day EMA5
307.10
Day EMA10
300.60
Day EMA12
299.40
Day EMA20
296.20
Day EMA26
294.40
Day EMA50
287.50
Day EMA100
277.80
Day EMA200
273.30
Delivery & Volume
Loading chart...

Day

51.20%

Week

59.70%

Month

58.20%

Delivery & Volume

322.75
Pivot
Resistance
First Resistance
331.50
Second Resistance
336.15
Third Resistance
344.90
Support
First Support
318.10
Second support
309.35
Third Support
304.70
Relative Strength Index
68.34
Money Flow Index
77.64
MACD
4.98
MACD Signal
2.91
Average True Range
13.60
Average Directional Index
15
Rate of Change (21)
15.80
Rate of Change (125)
26.93
Compare

Nureca Latest News

19 JAN 2026 | Monday
18 JAN 2026 | Sunday
17 JAN 2026 | Saturday

Please be aware that Nureca stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account